Omnicell Investor Presentation Deck
© 2023 Omnicell, Inc.
Omnicell, Inc.
Reconciliation of GAAP to Non-GAAP
(Unaudited, in thousands, except per share data and percentage)
Reconciliation of GAAP revenues to non-GAAP revenues:
GAAP revenues
Acquisition accounting impact related to deferred revenues
Non-GAAP revenues
Reconciliation of GAAP gross profit to non-GAAP gross profit:
GAAP gross profit
GAAP gross margin
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
Ransomware-related expenses, net of insurance recoveries
Severance-related expenses
Non-GAAP gross profit
Non-GAAP gross margin
Reconciliation of GAAP operating expenses to non-GAAP operating expenses:
GAAP operating expenses
GAAP operating expenses % to total revenues
Share-based compensation expense
Amortization of acquired intangibles
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Ransomware-related expenses, net of insurance recoveries
Executives transition costs
Severance-related expenses
Non-GAAP operating expenses
Non-GAAP operating expenses as a % of total non-GAAP revenues
$
$
$
$
$
Three Months Ended June 30,
2023
2022
298,973
298,973
134,443
45.0%
238
139,849
46.8%
2,268
2,900
126,695
42.4%
(11,821)
(5,135)
(246)
(841)
(483)
108,169
36.2%
$
$
331,386
302
331,688
158,092
47.7%
164,313
49.5%
2,160
3,537
302
222
145,607
43.9%
(15,053)
(5,308)
(263)
(3,340)
(1,152)
120,491
36.3%
22View entire presentation